| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.007 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.008 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |